从2026年开始,TrumpRx通过TrumpRx 削减GLP-1的价格。 Trump secures deal with drugmakers to cut GLP-1 prices via TrumpRx, starting 2026.

特朗普宣布与Eli Lilly和Novo Nordisk达成协议, 降低GLP-1重量损失药品(如Wegovy、Zepbound和Ozempic)的价格, 从2026年开始通过新网站TrumpRx(TrumpRx)提供。 Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices for GLP-1 weight-loss drugs like Wegovy, Zepbound, and Ozempic, making them available through a new website, TrumpRx, starting in 2026. 医疗保险和医疗补助受益人将每月支付50美元以下,而现金购买者可能每月支付150至449美元。 Medicare and Medicaid beneficiaries will pay as little as $50 per month, while cash buyers may pay $150 to $449 monthly. 该协议以“最富裕国家”的定价模式为基础,旨在将美国药物成本与其他富裕国家的药物成本统一起来,并包括对公司的关税减免。 The agreement, based on a "Most Favored Nation" pricing model, aims to align U.S. drug costs with those in other wealthy nations and includes tariff relief for the companies. 这些药物将因肥胖症和相关条件而报销,口头版预计每月费用为149至399美元。 The drugs will be covered for obesity and related conditions, with oral versions expected to cost $149 to $399 monthly. 尽管减少,但由于保险的变化,许多病人仍面临高昂的自付成本。 Despite the reductions, many patients still face high out-of-pocket costs due to insurance variability. 一名制药高管在活动中短暂倒下，但经过治疗并出院。 A pharmaceutical executive briefly collapsed during the event but was treated and released.